We make voice biomarkers work in the real world.

Symptonic is a research initiative at Aalto University, supported by Business Finland's Research to Business funding, dedicated to developing advanced technology for reliable detection that enables monitoring of various disorders through speech signal analysis remotely.Voice reflects neurological, respiratory and cognitive changes early, but today voice biomarkers fail outside controlled settings. Recordings vary by device, noise and compression, making results unreliable and blocking clinical adoption.Symptonic fixes this.

• Interested? Get in touch!

Making health insights as simple as speaking

Your voice holds powerful clues about your health. Our platform analyses subtle changes in speech to deliver objective, real-time insights – supporting patients and clinicians in detecting and managing a range of conditions with greater ease and accuracy.

Vision: Speech as a gateway to proactive care

We’re building a speech-based diagnostic platform to enable earlier detection, continuous monitoring, and more personalised care for a wide range of health conditions, including:• Neurological disorders – such as Parkinson’s and Alzheimer’s• Cardiovascular conditions – including heart failure• Mental health challenges – like depression and anxiety• Respiratory diseases – including asthma and COVID-19By turning everyday speech into clinically meaningful data, we aim to make health monitoring seamless, scalable, and accessible – using the device already in your hand.

Join us in shaping the future of healthcare

We are actively seeking collaborators for pilot projects to validate and enhance our technology.If you are an investor, healthcare provider, research institution, or technology company interested in pioneering speech-based diagnostics, we invite you to connect with us.

• Interested? Get in touch!